Navigation Links
Immucor Responds To FDA Notice
Date:6/26/2009

NORCROSS, Ga., June 26 /PRNewswire-FirstCall/ -- Immucor, Inc., (Nasdaq/NM: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced that yesterday the Food and Drug Administration ("FDA"), in an administrative action based on an early January 2009 inspection, issued a notice of intent to revoke the Company's biologics license with respect to its Reagent Red Blood Cells and Anti-E (Monoclonal) Blood Grouping Reagent product. The FDA has not ordered the recall of any of the Company's products.

"We take our regulatory responsibilities very seriously. We have been working diligently to improve our quality systems and processes, including the deficiencies identified by the FDA, with Our Quality Process Improvement Project. We are committed to completing this Project as quickly as possible," stated Dr. Gioacchino De Chirico, Immucor's President and Chief Executive Officer.

During its fiscal third quarter of 2009, the Company formalized efforts to improve its quality systems through the Quality Process Improvement Project. The Project expanded the role of consultants hired in April 2008. During fiscal 2009, the Company spent more than $2 million on the Project with the costs primarily consisting of consulting fees. As previously reported, during fiscal 2010, the Company expects to spend between $4.0 million and $4.5 million on the Project. The Company expects the Project to be completed during its third fiscal quarter of 2010.

"We have kept the FDA informed of the Project's objectives and progress by providing written updates to them on a monthly basis that detail our plans for corrective actions as well as the implementation of the correction action plans to prevent recurrence. The FDA has acknowledged that they are aware of our efforts to correct their identified deficiencies, but the letter indicates the FDA's action is bas
'/>"/>

SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Immucor Settles SEC Investigation
2. Immucor Responding to FTC Inquiry
3. Immucor To Acquire BioArray Solutions Ltd.
4. Immucor CEOs Italian Trial Moves Toward Second Phase
5. Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance
6. FDA Accepts Immucors Response to Warning Letter
7. Immucor Schedules Second Quarter Earnings Release and Conference Call
8. Immucor and Alverno Clinical Laboratories Sign Five-Year Automation Agreement
9. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
10. Updated Drug Development Scrip Report Responds to the Pharma Industrys Major Changes
11. Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Graphite Metallizing Corporation announces GRAPHALLOY® ... bearings are uniquely suited to prevent loss of lubrication ... the high temperatures . , Recently, a manufacturer ... engineers at Graphite Metallizing to overcome problems with movement ... operation, pans containing blocks of powder mixture are loaded ...
(Date:7/31/2014)... July 31, 2014 According to ... "Electrodes for Medical Devices Market (Diagnostic Electrodes - ECG, ... - TENS, Pacemakers, Defibrillators, Electrosurgical and Other Electrodes) - ... 2013 - 2019," the global electrodes market for medical ... and is estimated to reach a market worth USD ...
(Date:7/31/2014)... California (PRWEB) July 31, 2014 CollabRx, ... that inform therapeutic decision-making in oncology, today announced that ... 14, 2014 to discuss the Company's financial results for ... an update about the business in the current fiscal ... call beginning on Thursday, August 14, 2014, at 5 ...
(Date:7/31/2014)...  Smith & Nephew (LSE:SN, NYSE: ... announced its entry into the forefoot market with ... System. Comprised of three separate repair options, the ... repair and reconstruction, a metatarsal osteotomy guide, and ... fusion, also known as hammer toe correction. ...
Breaking Biology Technology:Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 2Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 4Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 5Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 6CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4
... Genomic Health, Inc. (Nasdaq: GHDX ) today reported financial ... Total revenue increased to $49.8 million in the first ... of 2010.  Product revenue was $49.5 million in the first quarter ... in the first quarter of 2010. Net loss ...
... /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX ... biotechnology company focused on researching, developing, manufacturing and ... release its first quarter 2011 unaudited financial results ... May 11, 2011 at 8:00pm (US Eastern ). ...
... May 3, 2011 Novavax, Inc. (Nasdaq: NVAX ... 2011 on Monday, May 9, 2011, before the U.S. financial ... and conference call hosted by Stanley C. Erck, President and ... 10:00 a.m. Eastern time. The webcast and ...
Cached Biology Technology:Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 2Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 3Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 4Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 5Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 6Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 7Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 83SBio Inc. Schedules Unaudited First Quarter 2011 Results 2
(Date:7/31/2014)... biomass burning burning forests to create agricultural ... agriculture and wildfires figures into both climate ... release of a new study by Stanford University ... the degree of that contribution had never been ... paper published July 30 in the Journal ...
(Date:7/31/2014)... Kansas State University researchers have completed a 20-year ... Flint Hills prairie at different times of the ... current late spring time frame has no measurable ... may have multiple benefits. , The study was ... Konza Prairie Biological Station fire chief, and Joseph ...
(Date:7/31/2014)... people make a rational choice to be liberal or ... it a matter of genetics?, Two political scientists from ... University say that neither conscious decision-making nor parental upbringing ... lean right. , A growing body of evidence shows ... core of political differences, the researchers say in the ...
Breaking Biology News(10 mins):Stanford professor finds that wildfires and other burns play bigger role in climate change 2Stanford professor finds that wildfires and other burns play bigger role in climate change 3Stanford professor finds that wildfires and other burns play bigger role in climate change 4Study finds benefits to burning Flint Hills prairie in fall and winter 2Study finds benefits to burning Flint Hills prairie in fall and winter 3Scientists find growing consensus: Political attitudes derive from body and mind 2
... more uses for local farm products were the focus of ... on selected Ontario farms. This province-wide initiative is the only ... farms to evaluate the effectiveness of using biodiesel in agriculture. ... adoption of biodiesel use on Ontario farms through a series ...
... medicine technique and molecular imaging to "see" programmed cell ... or abnormal cells—may help in early identification of those ... say researchers in the April Journal of Nuclear Medicine. ... noninvasively identify cell loss—or apoptosis—in heart failure patients using ...
... they can display a comparable pattern of neural activity ... Max Planck Institute for Dynamics and Self-Organization in Göttingen ... from neural cells which exhibit a predefined pattern dynamics. ... in getting closer to understanding which of the possible ...
Cached Biology News:Biodiesel study targets cleaner air, cleaner engines 2Heart failure: Intervention possibilities from imaging programmed cell loss 22 brains -- 1 thought 22 brains -- 1 thought 3